Bovine fetal palatine tissue infected with bovine papillomavirus type 4 (BPV-4) was implanted subcutaneously in athymic nude mice. The implants developed into cysts containing papillomas essentially the same as those in the natural host. In order to investigate the interaction of cocarcinogens with BPV-4 in cell transformation, the virus-infected implants were exposed in vivo to either the tumour promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) or the tumour initiator 7,12-dimethylbenz[a]-anthracene (DMBA). Papillomas were detected in a greater number of infected implants in the presence of either TPA or DMBA than in the absence of either of these chemicals indicating interaction between the virus and these two agents. Moreover, malignantly transformed cells arose with high frequency from infected implants that had been exposed to either chemical. In the presence of chemical and absence of virus or vice versa no neoplastic changes were seen histologically, indicating that cooperation between virus and cocarcinogen is required for transformation.
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Papillomaviruses induce benign tumours that regress spontaneously, but a number of papillomaviruses have greater oncogenic potential and include for example the cottontail rabbit papillomavirus, the bovine alimentary tract papillomavirus type 4 (BPV-4) and a subset of the human genital papillomaviruses (HPVs), most frequently HPV-16 and -18. However, papillomavirus infection is a necessary but insufficient step in itself towards the development of malignancy (Jackson et al., 1993) and it has been recognized that additional factors both intrinsic, such as the genetic background of the host, or extrinsic, such as chemical mutagens present in the environment or co-infections with other pathogens, are involved in the oncogenic process. The occurrence of alimentary cancer in cattle is related to the presence of two factors: bracken fern and BPV-4 (Jarrett et aI., 1978) . Bracken contains mutagenic and immunosuppressive chemicals (Evans et al., 1982) and Campo & Jarrett (1986) were able to reproduce experimentally the disease state observed in the field, showing that BPV-4, immunosuppression and exposure to bracken chemicals were essential for neoplastic transformation. It is likely that a series of events analogous to those identified for human colorectal carcinoma (Fearon & Vogelstein, 1990 ) is required for alimentary cancer in cattle, where one or more transforming steps are provided by BPV-4 and bracken cocarcinogens. It is not known however how BPV-4 and the cocarcinogens interact.
Studies of HPVs and BPV-4 are hindered by the lack of in vitro culture systems permissive for viral replication. Assembly of complete and infective virions occurs only in the more terminally differentiated epithelial cells, whereas the only cells that can undergo division in culture are the basal cells in which only early viral gene functions are expressed. In order to develop a system more amenable than cattle to experimental manipulation we have adopted the athymic nude mouse xenograft implant system (Gaukroger et al., 1989) originally described by Kreider et al. (1986) for HPV-11. In this system BPV-4-infected palatine tissue forms benign papillomas histologically identical to papillomas of the alimentary canal in cattle. Spontaneous transformation of one papilloma to a carcinoma has been observed (Gaukroger et al., 1991) . Given the interaction between virus and bracken chemicals in vivo we have investigated the interplay between the tumour promoter 12-0-tetradecanoylphorbol-13-acetate (TPA) and the tumour initiator 7,12-dimethylbenz[a]anthracene (DMBA) on the growth and neoplastic progression of BPV-4-induced papillomas in bovine palatine tissue implants in athymic nude mice. We show that BPV-4 can synergize with both TPA and DMBA with enhanced production of tumours. Athymic female nude mice, strain MF 1, were obtained from Harlan-Olac. They were housed in plastic isolators, given sterile food and water ad libiturn and maintained in accordance with the regulations stipulated by the Home Office of Great Britain. Bovine fetal tissue was cut into approximately 1 mm pieces and a single piece of tissue 0001-1673 © 1993 SGM was then implanted subcutaneously on the anterior left flank of anaesthetized mice using a 12-gauge cannula and trochar. Implants were allowed to grow for up to 20 weeks or to a maximum diameter of 1 cm as stipulated in the Home Office regulations. Implants were removed and bisected, one half being used for histology and the other half for biochemical analysis. To confirm that the implant-derived tumours were of bovine origin, primers for the first intron of the bovine Harvey-ras 2 gene were used (McCaffery et al., 1989) . These gave a product of 157 base pairs as expected, which hybridized to a bovinespecific internal oligonucleotide (data not shown).
Implants of uninfected tissue resulted in growth of epithelial cysts which were histologically identical to the cysts seen in renal implants (Gaukroger et al., 1991; Kreider et al., 1986) . They consisted of a basal cell layer overlaid by suprabasal and granular layers of characteristic bovine pattern culminating in keratinized squames (Fig. 1 a) .
Slow-release pellets incorporating either TPA or D M B A were purchased from Innovative Research of America and implanted at a subcutaneous site on the posterior left flank of anaesthetized mice following the instructions of the manufacturer. The pellets released chemicals over a period of 90 days. Control implants were placebo pellets that did not contain TPA or DMBA. Cysts which were histologically similar to those described above developed from non-infected tissue implants exposed to DMBA or TPA; during the whole time course of the experiments no papillomas or carcinomas developed from these implants.
Tissue was infected with BPV-4 as previously described (Gaukroger et all 1989) and implanted subcutaneously in mice exposed to placebo pellets only. After 20 weeks these implants developed into papillomas (Fig. 1 b) which had cells containing inclusion bodies indicative of production of virus particles (Jarrett et al., 1978) . The presence of viral D N A was monitored by the PCR technique using primers for the L1/L2 and E7 regions of the viral genome (Gaukroger et al., 1991) . Virtually all samples that had been infected with virus were positive and produced the expected products of 134 and 170 nucleotides respectively (Tables 1 to 3) . None of the papillomas that developed in the presence of placebo pellets showed neoplastic changes. In contrast, in the presence of either DMBA or TPA, several virus-infected implants displayed neoplastic changes as shown by histological analysis.
In the presence of TPA there was development of peglike protrusions of the basal cell layer, palisading of depolarized cells which were invading the surrounding stromal tissue and with the invading cell nuclei becoming hyperchromatic (Fig. 1 c) . Sixteen weeks after implantation 33"3% of virus-infected implants developed papillomas and 12.1% developed premalignant changes (Table 1) . Papillomas might have developed in more implants if they had been permitted to grow for a longer time. This is suggested by the presence of BPV-4 D N A detected by PCR (see above) in implants with no papilloma formation. TPA had an optimum effect on papilloma development when pellets containing 2 and 5 lag were used (Table 3 ). Higher doses were toxic for implant growth. There were, however, premalignant changes also at the highest dose tested.
These results show that, as is the case for BPV-1 (Amtmann & Sauer, 1982; Tsang & Stich, 1988) , BPV-4 cooperates with the tumour promoter TPA. BPV-4 transforms TPA-treated C127 mouse fibroblasts to malignancy and TPA induces both amplification and increased expression of the viral genome (Campo & Roe, 1986; Smith et al., 1987; Smith & Campo, 1988 Increased viral expression leads to enhanced cell transformation (Jaggar et al., 1990) . It is therefore reasonable to conclude, in agreement with these previous observations, that the increased production of papillomas in the bovine implants may be due, at least in part, to the effect of TPA on the viral functions of replication and transcription, although these have not been directly investigated in the present system. In addition, TPA has multiple effects on cellular functions (Rahmsdorf & Herrlich, 1990 ) which may be contributory factors in papilloma formation. DMBA induced greater changes in cellular phenotype with more advanced and aggressive lesions, histologically diagnosed as squamous cell carcinomas (Fig. 1 d) . There was depolarized proliferation of the lower keratinocytes, parabasal and basal cells, with invasion of the surrounding stroma. Hyperchromatic nuclei were present in the invading cells. These changes contrast with the ordered arrangement of the basal cell layer of virusinfected control cysts (Fig. 1 b) .
In the presence of DMBA 50.0 % of virus-infected implants developed papillomas and 65.0% developed carcinomas (Table 1) . In virus-infected implants not exposed to the chemical there was no papilloma development until week 20, whereas papilloma growth was detected in the DMBA-exposed implants as early as week 12 (Table 2 ). In addition carcinomas were already apparent at week 8 in the DMBA-exposed implants (Table 2) in marked contrast with the absence of carcinomas and fewer papillomas in the control implants. Although in cattle carcinomas derive from pre-existing papillomas (Jarrett et al., 1978) , it would appear that in DMBA-treated bovine implants carcinoma progression can bypass the late stages of papilloma development. A dose-response effect to DMBA could not be unequivocally confirmed because of the relatively small sample size (Table 3 ). The synergism between TPA and DMBA in enhancing tumour production could not be examined because of the toxicity of the combined chemicals at the doses tested. All the virus-infected implants analysed were positive for BPV-4 DNA (Tables 1 to 3 ). The presence of BPV-4 DNA was also investigated in tissue sections by in situ hybridization to digoxygenin-labelled viral DNA (Boehringer-Mannheim) on a panel of implants representative of the different treatments. Not all the implants positive for BPV-4 DNA by PCR were positive by in situ hybridization. This is probably due to the lower sensitivity of the latter technique but may also be related to the fact that the plane of section did not always pass through regions of the cysts containing virus-positive cells or papilloma fronds. However, in positive samples only the papilloma but not the carcinoma component hybridized to viral DNA (Fig. 1 e) , a result consistent with previous observations (Gaukroger et al., 1991; Campo et al., 1985) .
From histological examination alone it is not possible to say whether the difference in malignant phenotype between TPA-and DMBA-treated implants is due to the slower progression rate of the former, or to qualitative differences. Both types of implants are being transplanted into athymic mice and explanted into culture in order to answer these questions.
To date the possibility that papillomaviruses could interact with initiators has not received much experimental support. Indeed, Amtmann et al. (1987) reported that DMBA, unlike TPA, failed to stimulate the replication of papillomavirus DNA and to produce malignant tumours in Mastomys natalensis. In contrast, Pennie & Campo (1992) have recently shown that primary bovine cells can be transformed in vitro to a fully malignant phenotype by a single dose of the flavonoid quercetin, one of the most potent mutagens present in bracken fern (Evans et at., 1982) , followed by infection with BPV-4. In this case and in the present report, BPV-4 appears to stimulate the proliferation of chemically initiated cells. A similar situation may obtain in cattle, where BPV-4 would induce proliferation of cells initiated by bracken mutagens.
DMBA causes somatic mutations (Dipple et al., 1983 ) and DMBA-treated cells have been found to contain mutated and amplified c-Ha-ras (Bizub et al., 1986; Quintanilla et al., 1986 ) and c-erb-B genes (Wong, 1987) . This latter gene codes for the epidermal growth factor (EGF) receptor. Interestingly, in BPV-transformed cells there is an increased number of EGF receptors (Smith et aL, 1987) and the Ha-ras 1 gene is activated in BPV-4-associated carcinomas of the upper alimentary canal . Thus these effects could synergize with the BPV-4 oncoproteins and account for the malignant transformation of papillomas seen in field cases and in the present study. The contribution of other cellular genes, such as over-expression of c-myc as observed in human cervical carcinoma (Riou et al., 1987) , may be equally important.
Perhaps the ability of BPV-4 to generate tumours at high frequency in conjunction with DMBA or with TPA is not too surprising. These chemicals have a spectrum of initiating and promoting activities and one or other of their actions can predominate depending on the circumstances (Iversen & Astrup, 1984) . Neither BPV-4, TPA nor DMBA are complete carcinogens in the nude mouse implant system within the time scale of our observations. In combination, however, they can provide functions that transform bovine cells, confirming that virus and a chemical are essential for neoplastic progression.
